Lupus research identifies a prolactin-receptor target: experimental treatment protected mouse kidneys
A 2 November study found a shift in prolactin-receptor variants in immune cells from people with lupus. An experimental oligonucleotide reduced harmful immune activity and kidney damage in mice; no treatment benefit in patients has been demonstrated.





